8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jun 7, 2016)

Filed June 7, 2016For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed this 8-K on June 7, 2016, to disclose information that will be shared with securities analysts and investors during meetings scheduled between June 7 and June 30, 2016. The primary purpose of this disclosure is to reaffirm the company's full-year 2016 net income guidance. Specifically, the company expects net income to be greater than $9.65 per share, which includes over $1.15 per share of net unfavorable items. Excluding these items, the adjusted net income guidance remains strong, with the company continuing to expect it to be greater than $10.80 per share. This guidance is based on information available as of the first quarter of 2016 and does not incorporate any further adjustment items.

Key Highlights

  • 1Reaffirmation of 2016 full-year net income guidance.
  • 2Projected net income to be greater than $9.65 per share.
  • 3Anticipated net unfavorable items to be greater than $1.15 per share.
  • 4Continued expectation for adjusted net income to be greater than $10.80 per share.
  • 5Guidance does not include adjustment items beyond those reported in Q1 2016 earnings release.
  • 6Information intended for discussions with securities analysts and investors.
  • 7Forward-looking statements included, highlighting associated risks and uncertainties.

Frequently Asked Questions

The main purpose of this 8-K filing is to provide updated guidance and information to securities analysts and investors during upcoming meetings, specifically reaffirming the company's financial outlook for the full year 2016.

Elevance Health reaffirms its guidance that full-year 2016 net income will be greater than $9.65 per share. This includes an estimated impact of greater than $1.15 per share from net unfavorable items. Excluding these items, the company continues to expect adjusted net income to be greater than $10.80 per share.

No, this guidance does not include any adjustment items beyond those already reported in the company's first quarter 2016 earnings release. The guidance is based on information available at that time.

The filing mentions various risks, including increased government regulation, changes in healthcare costs and utilization, challenges with health insurance exchanges, the potential outcome of the Cigna acquisition (including integration and regulatory approvals), provider contract terms, competitor pricing, enrollment and product mix changes, Medicare and Medicaid program risks, financial strength ratings, litigation, cybersecurity, and general economic conditions.